Fanyi Meng
About
In The Last Decade
Fanyi Meng
36 papers receiving 346 citations
Peers
Comparison fields: 5 of 83
- Molecular Biology 177
- Oncology 95
- Cancer Research 94
- Immunology 77
- Biomedical Engineering 29
Countries citing papers authored by Fanyi Meng
This map shows the geographic impact of Fanyi Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanyi Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanyi Meng more than expected).
Fields of papers citing papers by Fanyi Meng
This network shows the impact of papers produced by Fanyi Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanyi Meng. The network helps show where Fanyi Meng may publish in the future.
Co-authorship network of co-authors of Fanyi Meng
This figure shows the co-authorship network connecting the top 25 collaborators of Fanyi Meng. A scholar is included among the top collaborators of Fanyi Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanyi Meng. Fanyi Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 5 | |
| 5 | 2 | |
| 6 | 21 | |
| 7 | 2 | |
| 8 | 6 | |
| 9 | 17 | |
| 10 | 9 | |
| 11 | 3 | |
| 12 | 4 | |
| 13 | 34 | |
| 14 | 1 | |
| 15 | 20 | |
| 16 | CCNB1 Expedites the Progression of Cervical Squamous Cell Carcinoma via the Regulation by FOXM1 | 2 |
| 17 | 10 | |
| 18 | microRNA-548b suppresses aggressive phenotypes of hepatocellular carcinoma by directly targeting high-mobility group box 1 mRNA | 1 |
| 19 | 1 | |
| 20 | 27 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.